Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026
Resmed (NYSE:RMD) will release its fourth quarter fiscal 2026 financial and operational results on Thursday, August 6, 2026, after the NYSE closes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Resmed (NYSE:RMD) will release its fourth quarter fiscal 2026 financial and operational results on Thursday, August 6, 2026, after the NYSE closes.
Management will host an earnings webcast at 1:30 p.m. PT / 4:30 p.m. ET, accessible only via the investor relations website, with replay options available.
Details
News Market Reaction – RMD
On Jul 1, the first trading day after this news, RMD closed 3.19% above the previous close.
Data tracked by StockTitan Argus for the Jul 1 session.
Key Figures
- Earnings release date
- August 6, 2026
- Q4 fiscal 2026 results after NYSE close
- Webcast time (US)
- 1:30 p.m. PT / 4:30 p.m. ET
- Management webcast to discuss Q4 FY2026 results
- London webcast time
- 9:30 p.m. BST
- International access to earnings webcast on August 6, 2026
- Sydney webcast time
- 6:30 a.m. AEST
- International access to earnings webcast on August 7, 2026
- Webcast replay delay
- ≈2 hours
- Replay available on investor relations website after live event
- Phone replay delay
- ≈3 hours
- Phone replay available after webcast conclusion
- Phone replay window
- August 6–20, 2026
- Period during which earnings call phone replay is accessible
- Conference ID
- 13761408
- Required code to access phone replay of earnings webcast
Previous Earnings date Reports
-
Announced Q3 FY2026 earnings release date and post-close webcast details.
-
Set Q2 FY2026 earnings date with webcast and replay information.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, June 30, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2026 on Thursday, August 6, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
- Location: https://investor.resmed.com
- Date: Thursday, August 6, 2026
- Time: 1:30 p.m. PT / 4:30 p.m. ET
- International: London, Thursday, August 6, 2026, 9:30 p.m. BST
Sydney, Friday, August 7, 2026, 6:30 a.m. AEST
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from August 6, 2026, until August 20, 2026, at:
- U.S.: +1 877.660.6853
- International: +1 201.612.7415
- Conference ID: 13761408
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
| For investors | For media |
| +1 858.221.3304 | +1 619.510.1281 |
| investorrelations@Resmed.com | news@Resmed.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.